Pricing
Login
Home
Charts
Search
Watchlist
Products

Zydus Lifesciences Ltd

ZYDUSLIFE
₹1,200.00-0.24%20 Nov 2026
Reports
Pharma Formulations

Zydus Lifesciences Ltd

ZYDUSLIFE
₹1,200.00
-0.24%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,19,700Cr
Close
Close Price
₹1,200.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
28.67
PS
Price To Sales
3.94
Revenue
Revenue
₹30,378Cr
Rev Gr TTM
Revenue Growth TTM
24.02%
PAT Gr TTM
PAT Growth TTM
-14.64%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
4,5055,5346,2085,2375,2696,5286,5746,1236,8657,5878,0177,910
Growth YoY
Revenue Growth YoY%
5.810.420.819.917.018.05.916.930.316.222.029.2
Expenses
ExpensesCr
3,4033,9034,1243,7763,8824,4024,4854,1065,0485,0336,0886,015
Operating Profit
Operating ProfitCr
1,1021,6312,0841,4611,3882,1262,0892,0171,8162,5541,9291,895
OPM
OPM%
24.529.533.627.926.332.631.833.026.533.724.123.9
Other Income
Other IncomeCr
38156636858-1391557527-263126159
Interest Expense
Interest ExpenseCr
20353225327785101130123156187
Depreciation
DepreciationCr
195205215234229238238302360508530605
PBT
PBTCr
9261,5471,9001,2711,1841,6721,9211,6941,3531,6601,3691,262
Tax
TaxCr
214321436373180423434386388318358334
PAT
PATCr
7341,2291,4648981,0041,2491,4871,2339651,3411,011928
Growth YoY
PAT Growth YoY%
25.3254.831.615.236.91.61.637.3-3.97.4-32.0-24.8
NPM
NPM%
16.322.223.617.119.119.122.620.114.117.712.611.7
EPS
EPS₹
7.811.714.19.110.211.614.612.510.412.79.69.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
4,5055,5346,2085,2375,2696,5286,5746,1236,8657,5878,0177,910
Growth YoY
Revenue Growth YoY%
5.810.420.819.917.018.05.916.930.316.222.029.2
Expenses
ExpensesCr
3,4033,9034,1243,7763,8824,4024,4854,1065,0485,0336,0886,015
Operating Profit
Operating ProfitCr
1,1021,6312,0841,4611,3882,1262,0892,0171,8162,5541,9291,895
OPM
OPM%
24.529.533.627.926.332.631.833.026.533.724.123.9
Other Income
Other IncomeCr
38156636858-1391557527-263126159
Interest Expense
Interest ExpenseCr
20353225327785101130123156187
Depreciation
DepreciationCr
195205215234229238238302360508530605
PBT
PBTCr
9261,5471,9001,2711,1841,6721,9211,6941,3531,6601,3691,262
Tax
TaxCr
214321436373180423434386388318358334
PAT
PATCr
7341,2291,4648981,0041,2491,4871,2339651,3411,011928
Growth YoY
PAT Growth YoY%
25.3254.831.615.236.91.61.637.3-3.97.4-32.0-24.8
NPM
NPM%
16.322.223.617.119.119.122.620.114.117.712.611.7
EPS
EPS₹
7.811.714.19.110.211.614.612.510.412.79.69.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9,4279,37711,90513,16614,25314,40415,11017,23719,54723,24227,14830,378
Growth
Revenue Growth%
9.0-0.527.010.68.31.14.914.113.418.916.824.0
Expenses
ExpensesCr
7,0967,4729,05710,18211,47011,01611,76913,37814,16316,18318,67322,183
Operating Profit
Operating ProfitCr
2,3311,9042,8482,9842,7833,3873,3413,8605,3847,0598,4758,195
OPM
OPM%
24.720.323.922.719.523.522.122.427.530.431.227.0
Other Income
Other IncomeCr
113128113191-250-160337-41827050-748
Interest Expense
Interest ExpenseCr
53459119434215912713081166439596
Depreciation
DepreciationCr
2923735395996976707137237649161,4082,003
PBT
PBTCr
2,0991,6152,3312,3821,4952,3992,8382,5904,8096,0276,6215,644
Tax
TaxCr
1771295645303201945125889781,4121,5951,399
PAT
PATCr
1,9211,4861,7661,8521,1762,2062,3262,0023,8314,6155,0264,245
Growth
PAT Growth%
62.0-22.718.94.8-36.587.65.5-13.991.420.48.9-14.6
NPM
NPM%
20.415.814.814.18.315.315.411.619.619.918.514.0
EPS
EPS₹
19.214.517.418.111.520.943.819.338.145.050.641.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9,4279,37711,90513,16614,25314,40415,11017,23719,54723,24227,14830,378
Growth
Revenue Growth%
9.0-0.527.010.68.31.14.914.113.418.916.824.0
Expenses
ExpensesCr
7,0967,4729,05710,18211,47011,01611,76913,37814,16316,18318,67322,183
Operating Profit
Operating ProfitCr
2,3311,9042,8482,9842,7833,3873,3413,8605,3847,0598,4758,195
OPM
OPM%
24.720.323.922.719.523.522.122.427.530.431.227.0
Other Income
Other IncomeCr
113128113191-250-160337-41827050-748
Interest Expense
Interest ExpenseCr
53459119434215912713081166439596
Depreciation
DepreciationCr
2923735395996976707137237649161,4082,003
PBT
PBTCr
2,0991,6152,3312,3821,4952,3992,8382,5904,8096,0276,6215,644
Tax
TaxCr
1771295645303201945125889781,4121,5951,399
PAT
PATCr
1,9211,4861,7661,8521,1762,2062,3262,0023,8314,6155,0264,245
Growth
PAT Growth%
62.0-22.718.94.8-36.587.65.5-13.991.420.48.9-14.6
NPM
NPM%
20.415.814.814.18.315.315.411.619.619.918.514.0
EPS
EPS₹
19.214.517.418.111.520.943.819.338.145.050.641.9
Sales CAGR
1 Year17%
3 Years16%
5 Years14%
TTM24%
EBITDA CAGR
1 Year20%
3 Years30%
5 Years20%
TTM8%
PAT CAGR
1 Year9%
3 Years36%
5 Years18%
TTM-15%
Avg. ROCE
1 Year18%
3 Years21%
5 Years19%
TTM15%
CFO / EBITDA
1 Year25%
3 Years58%
5 Years60%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
102102102102102102102101101101101100
Reserves
ReservesCr
5,5976,8588,64210,28410,27312,89016,89717,41519,72923,85327,01127,718
Current Liabilities
Current LiabilitiesCr
3,4615,3066,0837,3438,2697,8617,8275,5275,3409,04215,71218,024
Non Current Liabilities
Non Current LiabilitiesCr
1,2552,7993,0474,4613,7071,0949155411,8401,8027,1137,261
Total Liabilities
Total LiabilitiesCr
10,55115,22118,06523,48323,68723,88527,79525,75629,28137,20252,40755,607
Current Assets
Current AssetsCr
4,2806,0228,2308,4988,7158,71612,09510,00811,42017,04619,90618,434
Non Current Assets
Non Current AssetsCr
6,2709,1989,83614,98514,97115,16915,70015,74817,86120,15632,50137,173
Total Assets
Total AssetsCr
10,55115,22118,06523,48323,68723,88527,79525,75629,28137,20252,40755,607
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
102102102102102102102101101101101100
Reserves
ReservesCr
5,5976,8588,64210,28410,27312,89016,89717,41519,72923,85327,01127,718
Current Liabilities
Current LiabilitiesCr
3,4615,3066,0837,3438,2697,8617,8275,5275,3409,04215,71218,024
Non Current Liabilities
Non Current LiabilitiesCr
1,2552,7993,0474,4613,7071,0949155411,8401,8027,1137,261
Total Liabilities
Total LiabilitiesCr
10,55115,22118,06523,48323,68723,88527,79525,75629,28137,20252,40755,607
Current Assets
Current AssetsCr
4,2806,0228,2308,4988,7158,71612,09510,00811,42017,04619,90618,434
Non Current Assets
Non Current AssetsCr
6,2709,1989,83614,98514,97115,16915,70015,74817,86120,15632,50137,173
Total Assets
Total AssetsCr
10,55115,22118,06523,48323,68723,88527,79525,75629,28137,20252,40755,607

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,8941,3129191,2822,9323,2942,1052,6893,1966,7812,117
Investing Cash Flow
Investing Cash FlowCr
-864-2,872-974-4,239-1,012-725-1,0001,535-1,475-8,358-8,296
Financing Cash Flow
Financing Cash FlowCr
-9352,316521,885-1,528-2,548-868-4,400-1,7791,9955,807
Net Cash Flow
Net Cash FlowCr
95756-3-1,07239122236-177-58419-373
Free Cash Flow
Free Cash FlowCr
936-1,623-1162362,0432,4479371,6972,3135,139-530
CFO To PAT
CFO To PAT%
98.588.352.069.2249.4149.390.5134.383.4146.942.1
CFO To EBITDA
CFO To EBITDA%
81.368.932.343.0105.397.363.069.759.496.125.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,8941,3129191,2822,9323,2942,1052,6893,1966,7812,117
Investing Cash Flow
Investing Cash FlowCr
-864-2,872-974-4,239-1,012-725-1,0001,535-1,475-8,358-8,296
Financing Cash Flow
Financing Cash FlowCr
-9352,316521,885-1,528-2,548-868-4,400-1,7791,9955,807
Net Cash Flow
Net Cash FlowCr
95756-3-1,07239122236-177-58419-373
Free Cash Flow
Free Cash FlowCr
936-1,623-1162362,0432,4479371,6972,3135,139-530
CFO To PAT
CFO To PAT%
98.588.352.069.2249.4149.390.5134.383.4146.942.1
CFO To EBITDA
CFO To EBITDA%
81.368.932.343.0105.397.363.069.759.496.125.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
32,44845,37738,76435,48327,34445,13235,69849,7501,01,15289,12287,6631,19,700
Price To Earnings
Price To Earnings
16.830.521.819.223.321.18.025.426.219.717.428.7
Price To Sales
Price To Sales
3.44.83.32.70.91.61.21.52.72.01.73.9
Price To Book
Price To Book
5.76.54.43.42.63.52.12.85.13.73.24.3
EV To EBITDA
EV To EBITDA
14.625.614.914.112.014.411.613.118.712.711.716.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.158.060.058.559.961.557.958.663.568.569.069.0
OPM
OPM%
24.720.323.922.719.523.522.122.427.530.431.227.0
NPM
NPM%
20.415.814.814.18.315.315.411.619.619.918.514.0
ROCE
ROCE%
27.613.917.514.710.614.514.014.523.722.817.815.2
ROE
ROE%
33.721.420.217.811.317.013.711.419.319.318.515.3
ROA
ROA%
18.29.89.87.95.09.28.47.813.112.49.67.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
32,44845,37738,76435,48327,34445,13235,69849,7501,01,15289,12287,6631,19,700
Price To Earnings
Price To Earnings
16.830.521.819.223.321.18.025.426.219.717.428.7
Price To Sales
Price To Sales
3.44.83.32.70.91.61.21.52.72.01.73.9
Price To Book
Price To Book
5.76.54.43.42.63.52.12.85.13.73.24.3
EV To EBITDA
EV To EBITDA
14.625.614.914.112.014.411.613.118.712.711.716.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
62.158.060.058.559.961.557.958.663.568.569.069.0
OPM
OPM%
24.720.323.922.719.523.522.122.427.530.431.227.0
NPM
NPM%
20.415.814.814.18.315.315.411.619.619.918.514.0
ROCE
ROCE%
27.613.917.514.710.614.514.014.523.722.817.815.2
ROE
ROE%
33.721.420.217.811.317.013.711.419.319.318.515.3
ROA
ROA%
18.29.89.87.95.09.28.47.813.112.49.67.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,52,2511,78,3741,19,7001,16,1191,14,3161,10,0771,03,510
Close PriceClose₹1,884.904,689.501,200.001,390.201,415.002,665.001,799.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.2579.2128.6741.3639.4549.0526.09
Price To SalesPS7.3410.253.943.514.067.162.80
RevenueRevenueCr61,63117,40030,37833,09728,13915,37936,913
Revenue Growth TTMRev Gr TTM%12.1%42.1%24.0%-3.5%-0.7%13.5%13.5%
PAT Growth TTMPAT Gr TTM%4.9%-1.9%-14.6%-51.9%-47.4%27.6%16.5%
Market CapitalizationMkt CapCr4,52,2511,78,3741,19,7001,16,1191,14,3161,10,0771,03,510
Close PriceClose₹1,884.904,689.501,200.001,390.201,415.002,665.001,799.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.2579.2128.6741.3639.4549.0526.09
Price To SalesPS7.3410.253.943.514.067.162.80
RevenueRevenueCr61,63117,40030,37833,09728,13915,37936,913
Revenue Growth TTMRev Gr TTM%12.1%42.1%24.0%-3.5%-0.7%13.5%13.5%
PAT Growth TTMPAT Gr TTM%4.9%-1.9%-14.6%-51.9%-47.4%27.6%16.5%
Interviews